Challenges in addressing the knowledge gap on endomyocardial fibrosis through community-based studies
Jenisse Mbanze1, Basilio Cumbane1, Rolando Jive1
1Mozambique Institute for Health Education and Research, Maputo, Mozambique.
Cardiovascular Diagnosis and Therapy
|May 19, 2020
Summary
Endomyocardial fibrosis (EMF) is a challenging cardiovascular disease affecting young people in low-income countries. Echocardiographic screening aids early detection, but community research faces significant rural barriers.
Area of Science:
- Cardiovascular Medicine
- Global Health
- Epidemiology
Background:
- Endomyocardial fibrosis (EMF) is a poverty-related cardiac condition predominantly affecting young individuals in low-income countries.
- Its unknown etiology, delayed diagnosis, and high morbidity/mortality highlight global research disparities.
- Current understanding is limited by the inability to detect early disease stages in endemic rural areas.
Purpose of the Study:
- To investigate challenges and lessons learned in implementing community-based research for EMF in a highly endemic region.
- To explore the utility of echocardiographic screening for early EMF detection in asymptomatic individuals.
- To discuss how technological advancements and collaborations can advance EMF research.
Main Methods:
- Community-based epidemiological study in southern Mozambique.
- Echocardiographic screening using standard diagnostic criteria.
- Qualitative assessment of research implementation challenges.
Main Results:
- Echocardiographic screening demonstrated increased sensitivity and precision for diagnosing EMF, including asymptomatic cases.
- Significant socioeconomic, cultural, geographical, and administrative barriers were identified in conducting rural research.
- The study highlights the need for tailored approaches to overcome constraints in endemic settings.
Conclusions:
- Early detection of endomyocardial fibrosis is feasible through community-based echocardiographic screening.
- Overcoming rural research barriers is crucial for understanding EMF pathogenesis and improving patient outcomes.
- Collaborative partnerships and technological integration offer future research avenues for neglected cardiovascular diseases.
More Related Videos
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
180
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
180
Myocarditis I: Introduction
273
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
273
Cardiomyopathy IV: Restrictive Cardiomyopathy
349
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
349
Cardiomyopathy I: Introduction and Classification
393
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
393
Cardiomyopathy III: Hypertrophic Cardiomyopathy
277
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
277
Cardiomyopathy V: Interprofessional Care
219
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
219


